menu close
www.setpointmedical.com

SetPoint Medical Stock

Company Profile:

SetPoint Medical develops neuron-modulation platform technology to treat a variety of acute and chronic diseases. SetPoint Medical is dedicated to treating patients with debilitating inflammatory diseases, such as Crohn's Disease and rheumatoid arthritis, using proprietary implantable neuromodulation devices.

Sign up for SecondMarket™ to view the market and buy or sell SetPoint Medical Stock
Buy + Sell

SetPoint Medical Funding

Sign up to gain insights into SetPoint Medical funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Feb 04, 2025 Series F 25.00M
Price
Valuation
Jan 18, 2023 Series F 55.00M
Price
Valuation
Jan 22, 2021 Series E 12.05M
Price
Valuation
Oct 30, 2020 Series E 52.36M
Price
Valuation
Aug 28, 2017 Series D 30.00M
Price
Valuation
Aug 21, 2015 Series C 15.11M
Price
Valuation
Aug 08, 2013 Series C 30.61M
Price
Valuation
Oct 13, 2010 Series B 5.00M
Price
Valuation
May 14, 2009 Series A 4.00M
Price
Valuation
May 17, 2007 Series A 6.00M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

SetPoint Medical Management Team

  • Chief Medical Officer

    David Chernoff

  • Co-Founder

    Kevin Tracey

  • Director

    Blake Wu

  • Director

    Steve Winick

  • Founder

    James Broderick

  • Director

    Hank Plain

  • Co-Founder

    H. Shaw Warren

  • Director

    Zack Scott

  • CEO, Director

    Murthy Simhambhatla

  • Director

    Juan-Pablo Mas

  • Chairman

    Allan Will

  • Chief Financial Officer

    Seth Rohan

SetPoint Medical Major Investors

  • Catalio Capital Management

  • Aethan Capital, Inc.

  • Richard King Mellon Foundation

  • Medtronic Inc

  • Topspin Partners

  • Midas Capital

  • Foundation Medical Partners LP

  • Covidien Ventures

  • Ascendum Capital

  • SVE Capital

  • Citta Capital

  • Boston Scientific

  • Gilmartin Capital

  • Action Potential Venture Capital

  • Shangbay Capital

  • Morgenthaler Ventures

  • Revelation Partners

  • Asahi-Kasei Corporation

  • Euclidean Capital

  • Catalio Capital Management

  • Viking Global Investors

  • Norwest Venture Partners

  • New Enterprise Associates Inc (NEA)

Learn More About SetPoint Medical Stock

Buy SetPoint Medical Stock
01

SetPoint Medical stock does not trade on public stock exchanges. SetPoint Medical stock is considered a private security and you need to be an accredited investor to trade shares. To invest in SetPoint Medical stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell SetPoint Medical Stock
02

SetPoint Medical Stock does not trade on public stock exchanges. In order to sell SetPoint Medical shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

SetPoint Medical Stock Price
03

SetPoint Medical does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view SetPoint Medical share price and other valuable private market data.

Read more about secondary market private company stock prices:

SetPoint Medical Stock Ticker Symbol
04

There is no ticker symbol for SetPoint Medical stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell SetPoint Medical Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell SetPoint Medical stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in SetPoint Medical Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in SetPoint Medical stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

SetPoint Medical Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

SetPoint Medical IPO
08

SetPoint Medical is a private company and has not had an IPO. There is currently no SetPoint Medical IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to SetPoint Medical IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell SetPoint Medical Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

A new biopharmaceutical company using revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Inariag-Logo

Inari Agriculture

Uses AI-powered predictive design and gene editing to create sustainable, nature-positive seeds for a more efficient food system.

Rakuten Medical-Logo

Rakuten Medical

Developing precision, cell-targeting investigational therapies on its Illuminox platform, which have shown rapid and selective cell killing and tumor necrosis in pre-clinical studies.

Generate Biomedicines-Logo

Generate Biomedicines

Generative biology company with a revolutionary approach to drug development.

Source: Nasdaq Private Market Tape D™